You are here

ECCO

SIOG is a member organisation of ECCO since 2015. As one of the 24 members societies, SIOG seats on the ECCO board, participate in the discussions on the strategy and define the policies of ECCO.

ECCO is a not-for-profit federation that exists to uphold the right of all European cancer patients to the best possible treatment and care, promoting interaction between all organisations involved in cancer at European level. Through its 24 Member Societies - representing over 80 000 professionals.

As a member of ECCO, SIOG is given the opportunity to provide the voice of European geriatric oncology professionals and engage with policy-makers to ensure that cancer and older patients stay at the top of the EU agenda. Through ECCO’s Policy and Advocacy activities, SIOG engages in oncopolicy: planned and sustained interaction with EU policy-makers as well as third-party stakeholders to anticipate and proactively shape EU cancer health and research policy addressing the specific needs of older patients.

In the past months, SIOG has been involved in several ECCO projects:

Read more about ECCO's latest news

 2017 ERQCCs: The drafting commences!

Representatives of ECCO’s member societies and patient advisory committee gathered in Brussels in May to kick-off the development of new consensus documents outlining the Essential Requirements for Quality Cancer Care for melanoma and oesophageal and gastric cancer.

ECCO essential requirements for quality cancer care (ERQCC) are checklists and explanations of organisation and actions that are necessary to give high-quality care to patients who have a specific tumour type. They are written by European experts representing all disciplines involved in cancer care.

ERQCCs were developed for colorectal cancer and sarcoma in 2016 with supplementary activity now being undertaken to ensure their wide dissemination. Considerations on measurement of ERQCC implementation will be made by the ECCO Oncopolicy Committee in June 2017.

The recent ERQCCC meeting on 8th and 9th May gathered information and perspectives from ECCO’s members on the main considerations to be included in ERQCCs on melanoma and oesophageal and gastric cancer. Drafts of the new ERQCCs will be shared and developed over the summer with finalisation in Autumn 2017.

ECCO President Peter Naredi said: “It is exactly for projects like the ERQCCs that ECCO is so necessary. No other forum exists to bring together the great breadth of healthcare professionals involved in cancer care and to forge consensus expressions of our combined views to health system decision-makers. Efforts to achieve system improvement can be greatly strengthened when our organisations come together in this way.”

SIOG consulted on ECCO draft position statement on integrated care

SIOG has recently been consulted to contribute to a potential position statement on integrated care. 
The paper emerges from discussions held during the primary care track of ECCO2017. Key points in the draft paper include calls for:

  • A multidisciplinary and patient-centric approach to integrated cancer care, in order to achieve best outcomes and quality of care for patients
  • Predefined coordination of the total care process, with clearly defined roles and responsibilities for all involved healthcare professionals
  • Concerted attention to improving communication between the differing professionals and sectors involved in cancer care, including via IT investment and improvement, and integration of education

Commenting on the paper, Ian Banks, Chair of the ECCO Patient Advisory Committee, remarked: “ECCO’s unique position as a multi-disciplinary organisation, provides it with a powerful voice on the topic of integrated care. If approved by the ECCO Board, the position statement can be a springboard to impactful policy activities.”

For further information contact Patient Affairs Manager, Francoise Van Hemelryck Francoise@ecco-org.eu

 

Two SIOG key opinion leaders involved in ERQCCs on Sarcoma and Colorectal Cancer presented at European Parliament

ECCO President Peter Naredi has recently accepted several invitations to present to high level audiences about the recently published Essential Requirements for Quality Cancer Care (ERQCC) covering the tumour types of sarcoma and colorectal cancer. The engagements have included two events in the European Parliament.

Speaking about the ongoing ERQCC communication activity, Peter Naredi said:

"The 2016 ERQCC documents on sarcoma and colorectal cancer set out important visions for multidisciplinary practice and I thank again the contributions from ECCO members that made them possible.

However, we all know that writing a document is not enough. Our challenge now is to bring the vision of practice articulated in the ERQCCs to life by communicating it to those in a position to make change happen.

These events in the European Parliament are just the start of a year long planned communication  campaign and we will keep members informed and engaged in these activities via this newsletter and other communications.

Meanwhile, I’m delighted that progress is already being made for the 2017 ERQCCs for melanoma and oesophageal and gastric cancer, and that already thought is being given to the 2018 ERQCCs. The ERQCCs represent an exciting new area of activity for ECCO, and an important realisation of its guiding mission on multidisciplinarity."

Further information about the 2016 ERQCCs is available here.

Further information about the events in the European Parliament:
EuropaColon website
Euractive Website

 

SIOG involved in the OECD consultation on sustainable access to innovative therapies

SIOG, like all other ECCO members, has been alerted to a current consultation opportunity relating to access to treatment. A consultation is currently being conducted by the Organisation for Economic Co-operation and Development (OECD) on ‘Sustainable Access to Innovative Therapies’, with a deadline of 1st May.

The consultation has been commissioned by the French Ministry of Health as part of a broader initiative “to promote an international and high-level dialogue between stakeholders on access to innovative pharmaceuticals and sustainability of pharmaceutical spending.”

The initiative has also been endorsed by OECD member countries and by Health Ministers at the G7 Health Ministerial meeting in Kobe, on 11-12 September 2016. The overall objective is “to improve patient access to innovative treatments and ensure the sustainability of health spending as well as continued innovation that meets patient needs.”

The consultation is available here

Commenting on the consultation, Philip Poortmans, Chair of the ECCO Oncopolicy Committee and ECCO President-elect, remarked:

"This consultation is an opportunity to communicate the importance of access to non-pharmaceutical as well as pharmaceutical treatments. International dialogue should be occurring on all aspects of access, a point which will be raised further in a shortly-to-be-published ECCO paper on access to care in the European Journal of Cancer".